Newborn screening, informed consent, and future use of archived tissue samples

Area of Science:

• Medical Genetics
• Public Health
• Bioethics

Background:

• Newborn screening programs, mandated in most US jurisdictions, successfully identify infants with genetic diseases for early treatment.
• Surplus, stored newborn blood samples are valuable resources for genetic and biomedical research.
• Accessing these stored samples for research raises ethical concerns regarding consent and data usage.

Purpose of the Study:

• To address the ethical considerations surrounding the use of surplus newborn screening blood samples in genetic research.
• To propose an informed consent protocol to reconcile the rights of individuals and parents with the needs of researchers.

Main Methods:

• Ethical analysis of current practices in newborn screening and sample storage.
• Review of existing legal and ethical frameworks concerning genetic research and informed consent.
• Development of a recommended informed consent model for utilizing residual newborn screening samples.

Main Results:

• Current newborn screening protocols often lack explicit parental consent for the use of residual samples in research.
• Genetic research utilizing these samples offers significant potential for advancing understanding and treatment of genetic diseases.
• An informed consent process is crucial for ethical research and protecting individual autonomy.

Conclusions:

• Balancing the public health benefits of genetic research with individual privacy and parental rights requires a robust informed consent strategy.
• Implementing an informed consent protocol for surplus newborn screening samples can facilitate ethical research while respecting participant rights.
• This approach supports the continued advancement of genetic medicine and the development of new therapies for genetic disorders.